5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.21%
Negative revenue growth while VALMT.HE stands at 28.70%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
1.22%
Gross profit growth under 50% of VALMT.HE's 25.24%. Michael Burry would be concerned about a severe competitive disadvantage.
-52.94%
Negative EBIT growth while VALMT.HE is at 49.32%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-52.94%
Negative operating income growth while VALMT.HE is at 49.32%. Joel Greenblatt would press for urgent turnaround measures.
-50.15%
Negative net income growth while VALMT.HE stands at 56.86%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-45.30%
Negative EPS growth while VALMT.HE is at 55.88%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-45.30%
Negative diluted EPS growth while VALMT.HE is at 55.88%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-8.86%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-8.86%
Reduced diluted shares while VALMT.HE is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
104.57%
OCF growth above 1.5x VALMT.HE's 44.44%. David Dodd would confirm a clear edge in underlying cash generation.
36.70%
FCF growth 50-75% of VALMT.HE's 49.53%. Martin Whitman would see if structural disadvantages exist in generating free cash.
-22.84%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 18.77%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
2.50%
5Y revenue/share CAGR under 50% of VALMT.HE's 38.18%. Michael Burry would suspect a significant competitive gap or product weakness.
30.22%
3Y revenue/share CAGR at 75-90% of VALMT.HE's 37.84%. Bill Ackman would expect new product strategies to close the gap.
113.59%
10Y OCF/share CAGR under 50% of VALMT.HE's 323.79%. Michael Burry would worry about a persistent underperformance in cash creation.
29.03%
Below 50% of VALMT.HE's 489.78%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
88.76%
3Y OCF/share CAGR at 75-90% of VALMT.HE's 102.88%. Bill Ackman would press for improvements in margin or overhead to catch up.
123.28%
Below 50% of VALMT.HE's 1228.00%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
184.15%
5Y net income/share CAGR at 75-90% of VALMT.HE's 211.09%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
-24.70%
Negative 3Y CAGR while VALMT.HE is 503.67%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
42.76%
Below 50% of VALMT.HE's 149.00%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
70.15%
5Y equity/share CAGR above 1.5x VALMT.HE's 25.75%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
45.96%
3Y equity/share CAGR above 1.5x VALMT.HE's 15.80%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.86%
Firm’s AR is declining while VALMT.HE shows 6.36%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-5.05%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.87%
Asset growth at 50-75% of VALMT.HE's 3.11%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
13.09%
Similar to VALMT.HE's 13.49%. Walter Schloss finds parallel capital usage or profit distribution strategies.
-3.84%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
19.56%
We expand SG&A while VALMT.HE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.